Archive for the ‘research’ Category

ACTION: Flood Inboxes of Task Force on Health Care Monopolies and Collusion

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32992416

Calling on all Lyme patients, caregivers, and clinicians across the globe!

Carl Tuttle
Hudson, NH, United States
Oct 26, 2024

The following timeline for the deliberate mishandling of Lyme disease was forwarded to Attorney Katrina Rouse of the United States Antitrust Division, head of a Task Force on Health Care Monopolies and Collusion. Please forward your respectful request for an investigation into the collusion to deny chronic Lyme disease which has stifled research for better antimicrobials in treating this antibiotic resistant/tolerant superbug. Your email should describe how this denial has affected your ability to obtain treatment and affordable healthcare. What has been deceitfully established here in the US is being emulated across the globe.

Note to clinicians: Your experience on the front lines in treating chronic Lyme and witnessing the devastation first hand should be described in detail.

Let’s flood the inboxes of these two attorneys!

Contact info for Attorney Katrina Rouse and Assistant Attorney General Jonathan Kanter

Katrina Rouse: katrina.rouse@usdoj.gov

Jonathan Kanter: jonathan.kanter@usdoj.gov

Letter to Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “grace.marx@cuanschutz.edu” <grace.marx@cuanschutz.edu>, “gmarx@cdc.gov” <gmarx@cdc.gov>
Cc: “katrina.rouse@usdoj.gov” <katrina.rouse@usdoj.gov>, “jonathan.kanter@usdoj.gov” <jonathan.kanter@usdoj.gov>
Date: 10/25/2024 9:11 AM EDT
Subject: Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects

Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects
https://www.hhs.gov/oidp/initiatives/tick-borne-diseases-associated-illnesses-national-community-engagement-initiative/index.html3:00 pm – 3:20 pm   A Clinician Toolkit: Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease By Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention

Dear Dr. Marx,

I listened to your presentation yesterday with great interest and I must congratulate you for your outstanding performance in suppressing all evidence of persistent infection; chronic Lyme disease.

We have studies proving persistent infection after antibiotic treatment for mice, dogs, ponies, monkeys, cows, iris biopsy, and ligamentous tissue but if you perform a simple Google search for the following statement, “There is no convincing scientific evidence that chronic Lyme exists” you will find the top search results are connected to “elements of academic medicine” involved in the denial of the late stage Lyme epidemic.

In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of Lyme patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics. The patient died when the insurer refused additional IV antibiotics. Here is a copy of Logan’s CDC positive culture report for your review.

(Vicky Logan’s Chronic Lyme Autopsy results Page #1, 2, 3, 4, 5, 6, 7)

There are 700 peer-reviewed publications referencing persistent infection and in a 2018 study all patients were culture positive even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

Thirty-four years ago Dr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits.

Here is Dr. Steere’s 1990 publication summary for your review:

The New England Journal of Medicine 

Published November 22, 1990

Chronic neurologic manifestations of Lyme disease
https://www.nejm.org/doi/full/10.1056/NEJM199011223232102

The chart below summarizes Lyme research funded by the NIH and only 2.5% has been allocated for treatment:

https://www.dropbox.com/scl/fi/4fpjivy7stiztfs5ib6sz/NIH-Lyme-Research.png?rlkey=71yrfa6r7e6osq2he7qwsjj75&dl=0

For the record there are many infections requiring long-term antibiotics so why Klempner stopped his NIH funded antibiotic treatment trials for Lyme after 90 days makes absolutely no sense whatsoever:

From the following publication:

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
https://www.dovepress.com/benefit-of-intravenous-antibiotic-therapy-in-patients-referred-for-tre-peer-reviewed-fulltext-article-IJGM

Infections requiring long-term antibiotics:

https://www.dropbox.com/scl/fi/pserdbenw4n1vovv14z2a/Infections-requiring-long-term-antibiotics.jpg?rlkey=281zg7alxl4gqm2e2jipy9szj&dl=0

Lyme misdiagnosed/undiagnosed for months, years or decades is far more incapacitating than “acute” Lyme and 2-4 weeks of antibiotics does not scratch the surface of this well-established/immune suppressive infection. These are the patients who need help the most but have been excluded in research for decades. There are countless stories of patients seroconverting after the initial few doses of Doxycycline and now that a toxin has been identified that puts Lyme disease in an altogether different category of infection:

Toxins 
Published: 21 May 2024

Borrelia burgdorferi 0755, a Novel Cytotoxin with Unknown Function in Lyme Disease
https://www.mdpi.com/2072-6651/16/6/233

So it would appear that one way to get a medical association (AMA) to go along with the suppression of evidence is to throw them a boatload of money… five million taxpayer dollars to be exact for a so-called IDSA biased “Clinician Toolkit”  (CDC grant number  NU50CK000597)

This controlling of the narrative has caused unimaginable pain and suffering all across America as insurance companies refuse to pay for long-term treatment, personal bankruptcies from out-of-pocket expenses to treat chronic infection, suicides from despair all while Valneva Received FDA Fast Track Designation for its Lyme Disease Vaccine.

Chronic Lyme must be recognized and finally addressed with 100% attention to effective antimicrobials for all stages of disease.

Question:

Is collusion to control the narrative through suppression of the truth, facts and scientific references a criminal offense?

Carl Tuttle
Hudson, NH

Cc: Assistant Attorney General Jonathan Kanter, Attorney Katrina Rouse
Attorneys for the United States Antitrust Division

Assistant Attorney General Jonathan Kanter Announces Task Force on Health Care Monopolies and Collusion
https://www.justice.gov/opa/pr/assistant-attorney-general-jonathan-kanter-announces-task-force-health-care-monopolies-and

“Every year, Americans spend trillions of dollars on health care, money that is increasingly being gobbled up by a small number of payers, providers and dominant intermediaries that have consolidated their way to power in communities across the country,” said Assistant Attorney General Jonathan Kanter of the Justice Department’s Antitrust Division. “Led by Katrina Rouse, the task force will identify and root out monopolies and collusive practices that increase costs, decrease quality and create single points of failure in the health care industry.”

Category:

Activism, Lyme, research

Over 30 Schoolchildren Died Suddenly This Week & Damning Testimony Against ALL Vaccines

Canada has just killed an Ontario man in his late 40’s injured by the COVID shot under it’s “assisted suicide” laws funded by tax-payers. The Canadian government is euthanizing citizens for depression, hearing loss, autism, poverty and homelessness, but is also pushing to expand laws to include children and infants.

The group that worked to legalize the program now admits it’s been “abused” and that doctors have been coercing people into dying.

https://thepeoplesvoice.tv/over-30-u-s-schoolchildren-died-suddenly-this-week-as-deaths-surge-among-covid-vaxxed/

Over 30 U.S. Schoolchildren Died Suddenly This Week As Deaths Surge Among COVID-Vaxxed

Fact checked by The People’s Voice Community

October 12, 2024 Baxter Dmitry

At least thirty US school children whose parents were told the COVID mRNA shots were “safe and effective” died suddenly and unexpectedly in the US this week as the death toll continues surging among the vaccinated and boosted.

Many of the children died of medical emergencies including cardiac arrest and strokes as doctors warn they are now regularly witnessing “once-in-a-lifetime” disorders in children.

“This is the new normal… turbo cancers, died suddenly. My friend lost three friends in one week! Turbo cancers like this were virtually non-existent before the COVID shots,” explained MIT scientist and vaccine researcher, Steve Kirsch.

How long before we as a society can have an open and honest discussion about what is happening to the Covid-vaccinated before our eyes?  (See link for article)

A large scale study from Korea revealed that the Pfizer and Moderna COVID shots have the greatest cardiac risk.

For more:  https://madisonarealymesupportgroup.com/2020/12/21/warning-3150-injuries-in-1st-week-of-covid-vaccines-among-american-healthcare-workers-pregnant-women-included/ Latest VAERS data and mounting list of adverse reactions and death.

______________

https://x.com/newstart_2024/status/1849826194914459706  Video Here (Approx. 5 Min)

Damning Testimony Against ALL Vaccines

Dr. Brian Hooker’s damning testimony against all vaccines “My name is Dr. Brian Hooker, and I am a vaccine safety scientist serving as a chief scientific officer of Children’s Health Defense. I’m also the father of a severely vaccine injured adult son.

Next slide, please. This slide shows the expansion of the infant child vaccination schedule since 1962, as recommended by the CDC. Multivalent vaccines are counted based on the number of disease antigens. For example, the MMR vaccine counts as three doses. In 1962, children received five vaccine doses, and in 1986, the schedule expanded to 25 doses of five different vaccine formulations.

Shortly after the passage of the 1986 National Childhood Vaccine Injury Act, the law was amended to essentially erect a liability shield protecting vaccine and the schedule expanded dramatically. By 2023, 73 doses of 16 different vaccine formulations were given to children up to age 18.

The FDA approved these formulations individually only with minimal and inadequate safety testing, and the CDC has never tested the cumulative effect of the vaccine schedule on childhood health outcomes. However, independent researchers have assessed the outcomes of vaccinated versus unvaccinated children. Next slide, please.

This slide shows the results of a paper that Neil Miller, a medical journalist, and I published in the journal Sage Open Medicine in 2020. Here, only vaccines given during the first year of life were considered.  Any child who received one vaccine or more during the first year of life was considered vaccinated, and any child who received no vaccines during the first year of life was considered unvaccinated.

Deidentified records were taken directly from three medical practices in different locations within the US. The odds ratios or likelihood of a diagnosis is shown on the graphic. This demonstrates that vaccinated children were at least twice as likely to be diagnosed with developmental delays, ear infections, and gastrointestinal disorders.

The likelihood of an asthma diagnosis among the vaccinated group was 4.5 times higher than the unvaccinated group. Next slide, please. Affirming and extending these results is a study completed by Joy Garner of the control group that was published in the International Journal of Vaccine Theory Practice and Research in 2022.

Here, a control group of over 1,800 unvaccinated children recruited from 46 different states in the US were compared to the national average rates of the listed disorders. The national averages represent a population of children where 99.7% of the participants are vaccinated. Incidence of each disorder is shown as a percentage of each group of children on the graphic.

For each of the autoimmune, neurodevelopmental, and other disorders considered, the unvaccinated group fares much better with incidence rates between four and 20 times lower than their vaccinated counterparts. Next slide, please.

This is a comparison of the myocarditis diagnosis rates following the COVID-19 mRNA vaccines given during the pandemic. The first graphic on this slide is from a paper published by Mazzari et al. in the Journal Plus Medicine in 2022. It shows the incidence of myocarditis and pericarditis diagnoses within seven days of receiving either the first or second dose of the Moderna vaccine versus the unvaccinated control group, four males between 12 and 39 years of age.

The second graphic on the slide is from a paper published by Mvorak et al in the New England Journal of Medicine in 2021. It shows the incidence of myocarditis within 30 days of receiving the second Pfizer vaccine in the general population, as well as for 16 to 19 year old boys compared to unvaccinated controls.

Myocarditis is a serious disorder and 76% of all cases following COVID vaccination, as reported by VAERS, requires emergency care and or hospitalization. CDC significantly downplays myocarditis as a side effect of the vaccine. Vaccine injury is neither minor nor rare.

The 1986 National Childhood Vaccine Injury Act requires that the Department of Health and Human Services report to Congress on the state of vaccine safety in the U.S. every two years. It’s been almost 40 years since the 1986 act was passed, and HHS has never submitted a vaccine safety report to Congress.

Federal authorities are derelict in their duty to protect the people of the United States from debilitating and often life-changing vaccine adverse events. Thank you.”

______________

http:// (Approx. 9 Min)

BBC FINALLY acknowledge vaccine harms… but three years too LATE

Bev Turner on GB News

Oct. 27, 2024

BOOM!

Further damning vaccines is the fact that infant deaths due to vaccines are never listed on death certificates, but are listed as SIDS (sudden infant death syndrome) due to the lack of ICD (International Classification of Diseases) codes, sanctioned by the CDC and the WHO.  Coroners can’t choose to list a death as due to a vaccine even if they wanted to because no code exists for it.

Sudden Infant Death Syndrome or SIDS remains the leading cause of death for infants in the U.S.
This remains the perfect cover-up for vaccine deaths.

The youngest death from Pfizer COVID shot is a 5-month-old who died within 24 to 48 hours after injection. The youngest death after Moderna COVID shot is a one-year-old.  Source

Same story in both cases: found dead in the crib a couple of days after their injection. 

But in both cases it’s labeled SIDS.

Lastly, Dr. Andrew Wakefield states that a statement from the Federal Register says:

“The science of vaccine safety, whatever its merits, if there is doubt about a vaccine, that science can not be allowed to exist.”

That’s not science.

For more:

Category:

research, vaccines

Brazil Faces Same Problems With Lyme Disease As Seen in the USA

http://cameronmd.com/brazil-faces-problems-lyme-disease-seen-usa/

Brazil faces same problems with Lyme disease as seen in the USA

An article published in the Brazilian Journal of Microbiology entitled “Brazilian borreliosis with special emphasis on humans and horses” examines the growing number of cases in Brazil of Lyme disease, referred to, in that country, as the Lyme-like or Baggio-Yoshinari Syndrome (BYS).

By 

The authors take an in-depth look at BYS and how it compares to Lyme disease (LD) found in the United States. Although there are slight differences between the diseases, BYS and LD share similarities on many fronts. [1] “Despite the increasing number of suspect cases, this disease [BYS] is still neglected in Brazil by the medical and veterinary communities,” writes Basile and colleagues.

BYS causes some of the same symptoms seen in Lyme disease, such as erythema migrans, arthritis, neurological symptoms and cardiac disease. Both are difficult to diagnose.

“The disease is often unrecognized, especially at secondary or tertiary stages when patients do not remember what occurred months or years before the current disease,” stated Basile. “Certainly, many cases of unrecognized chronic neurological or articular disease are in fact cases of BYS not identified and treated at early stage.”

The capybaras, a popular Brazilian house pet, is a known reservoir for ticks infected with the Lyme-like or Baggio-Yoshinari Syndrome (BYS).

The Brazilian disease can also be multisystemic. “Baggio-Yoshinari Syndrome has been reported to cause neurological, cardiac, ophthalmic, muscle, and joint alterations in humans.” Furthermore, it has been associated with a high morbidity “due to the presence of symptom recurrence, severe reactive manifestations such as autoimmunity, and the need for prolonged treatment.”

According to Basile and colleagues, the disease progresses with recurrences, “especially if antibiotic treatment is initiated later than three months after infection.” Thus, treating the disease in its early stages is critical.

Cystic forms have been described, as well. “Because motile and spiral spirochetes were never isolated or cultured in Brazil, researchers from LIM-17 assumed that the etiological agent in Brazil was present in cystic form.”

The Brazilian patients may also be suffering from co-infections, as investigators identified other microrganisms in the blood of BYS patients. Tests showed “the occurrence of microorganisms with morphological structures similar to Mycoplasma spp., Chlamydia spp., and non-flagellated spirochetes in the peripheral blood of patients with BYS who were seropositive for B. burgdorferi sensu lato,” according to Basile. “Those patients exhibited negative serology for Mycoplasma spp. and Chlamydia spp.”

Additionally, laboratory testing for BYS is unreliable. There is a low sensitivity and specificity with the ELISA, enzyme immunosorbent assay, or western blotting for B. burgdorferi, in part because these tests utilize antigens from B. burgdorferi stricto sensu from the Northern Hemisphere.

Domestic pets have been described as potential reservoirs for ticks carrying the disease. The capybaras, a large rodent and popular house pet in Brazil, has been identified as a likely reservoir and is thus a threat in spreading the disease.

Wild and domestic animals can be infected. “Studies indicate that LB [Lyme borreliosis] in horses has clinical signs similar to the disease in humans, including fever and lethargy, arthritis, polysynovitis, lameness, muscle stiffness, abortion, meningitis, cranial neuritis, radiculoneuritis and encephalitis, uveitis, and premature death of foals,” according to Basile.

The authors’ findings reminds us that the challenges faced in the United States in gaining recognition for a disease that is growing in numbers and has the potential to cause chronic, debilitating illness is not unique to our country. The Brazilian patients suffering from the Lyme-like or Baggio-Yoshinari Syndrome are struggling to conquer the same obstacles.

“Lyme disease is a condition of extreme importance because it is a zoonosis that causes physical and psychological sequelae in affected individuals. It remains poorly investigated in Brazil, especially in the field of veterinary medicine. Therefore, studies describing the unique aspects of the disease in Brazil and the etiological agents found are needed.”

References:

  1. Basile, R.C., et al., Brazilian borreliosis with special emphasis on humans and horses. Braz J Microbiol, 2016.

Update: Oliveira from the Ministry of Health, Brasilia, DF, Brazil was not able confirm Lyme-like borreliosis in Brazil in a letter in the journal Travel Medicine and Infectious Disease.1 “The interpretations of the results have not followed those recommended by the CDC.” writes Oliveira. Only three cases of Lyme-like borreliosis were identified. “This evidence reinforces the hypothesis that Lyme borreliosis does not occur in Brazil.” writes Oliveira.

  1. de Oliveira SV, Faccini-Martinez AA, Cerutti Junior C. Lack of serological evidence for Lyme-like borreliosis in Brazil. Travel Med Infect Dis. 2018.

________________

**Comment**

Another perfect example of why the CDC must go.

This corrupt, inept organization rules the world.

Category:

Activism, Lyme, research, Testing, Ticks, Transmission

Ceftriaxone Cures a Chronic Lyme Patient (Who Took Lots of Other Things As Well)

https://www.researchgate.net/publication/379477460_Case_Report_Prolonged_Treatment_with_Ceftriaxone_Cures_A_Patient_with_Chronic_Lyme_Disease_Affiliation_History_of_the_Disease

Case Report : Prolonged Treatment with Ceftriaxone Cures A Patient with Chronic Lyme Disease Affiliation: History of the Disease

Authors:  Alexis Lacout
Christian Perronne
Michel Franck
Download full-text PDF

Abstract

This is the case of a 40-year-old immunocompetent, female patient presenting with a “polymorphic persistent syndrome after a possible tick bite” (SPPT), a syndrome officially recognized by the French High Authority for Health (HAS). This patient presented with polymorphic symptoms and was unable to walk without a walker. Only ceftriaxone was effective. She experienced several episodes of remission and relapse, when treatments were started and stopped.
Finally, it was possible to achieve a prolonged final remission, persisting for 3 years after the last anti-infective treatments had been stopped.  See link for full article
______________
**Comment**
A very interesting case study on a poor woman who like most Lyme/MSIDS patients have been through hell and back.  Thankfully, Dr. Christian Perrone came the the rescue and now this woman has her life back.
Cefriaxone is also called Rocephin.
For more:

Category:

Lyme, research, Treatment

How DMSO Treats ‘Incurable’ Autoimmune and Contractile Disorders

https://www.midwesterndoctor.com/p/how-dmso-treats-incurable-autoimmune?

How DMSO Treats “Incurable” Autoimmune and Contractile Disorders

The decades of research that could have prevented an immense amount of human suffering

A Midwestern Doctor

Oct 20, 2024

Story at a Glance:

•DMSO is a remarkably safe substance that effectively treats a variety of conditions (e.g., chronic pain, acute injuries, and strokes) that medicine has struggled with for decades. Many readers here have already experienced profound benefits from using it.

•DMSO is a powerful (but safe) anti-inflammatory agent that is often extremely helpful for autoimmune conditions. For example, it’s frequently used to treat asthma, inflammatory bowel diseases (e.g., ulcerative colitis and irritable bowel syndrome), interstitial cystitis (painful bladder syndrome), ITP, lupus, multiple sclerosis, myasthenia gravis, scleroderma, Sjogren’s syndrome, and uveitis.

•DMSO is also remarkably effective at stabilizing and refolding proteins. This allows it to treat a variety of “untreatable” genetic disorders, and conditions characterized by the abnormal accumulation of misfolded proteins in the body (e.g., amyloidosis) or chronic deposits of excessive contractile collagen (e.g., surgical scars, abdominal adhesions, Dupuytren’s contractures, and Peyronie’s disease). Two of the most dramatic examples of this are scleroderma and fibrodysplasia ossificans progressiva—both “untreatable” conditions where DMSO can provide truly lifesaving benefits.

•In this article, I will present the wealth of evidence substantiating each of those uses, share my theory on how the unusual antimicrobial properties of DMSO explain some of these benefits, and present DMSO treatment protocols for many of those disorders. Additionally, since many readers requested it, I put together a simplified guide on how to use DMSO orally or topically.

Dimethyl sulfoxide (DMSO) is a simple and readily available naturally occurring chemical that rapidly enters the body through the skin and has a variety of remarkable therapeutic properties. When it was discovered, its proponents believed it (much like antibiotics) represented a new therapeutic principle in medicine and once adopted, would completely change how medicine was practiced. Unfortunately, the FDA conducted a reprehensible campaign against it and was able to successfully bury it.

Since there are so many uses for DMSO, to effectively present them, I’ve had to comb through well over ten thousand pages of scientific literature and then order them into a logical sequence (of what will be roughly a nine-part series). For instance, in the first part of this series, I discussed how DMSO completely changed the management of neurological injuries and showed that were it to be adopted, millions would no longer be disabled from the common emergencies we view as insurmountable within the current medical paradigm (e.g., frequent disabilities from stroke and the inevitability of becoming a paraplegic after a spinal cord injury).  (See link for article)

_______________

**Comment**

DMSO has been a well-kept secret among those who are desperate enough to learn about it.  If you are new to it, go here for a basic article and helpful videos that explain it in layman’s terms as well as MSM, a derivative of DMSO.  I also include helpful info on dosages, etc.

I’ve used it many times over the years and always with good, measurable results.

I highly recommend reading a Midwestern Doctor’s thorough article in full as the good doctor goes through many conditions DMSO treats as well as the scientific studies and experiences behind them.

He goes through DMSO use for MS, Lupus, Asthma, Interstitial cystitis, Uveitis, inflammatory bowel diseases, Myasthenia gravis, Sjogren’s syndrome, as well as the possible bacterial component (even the challenges of pleomorphism) in many of these conditions and how DMSO is bacteriostatic, antiviral and antifungal.

You can use DMSO topically (recommended for newbies first), orally, intramuscularly, and intravenously.

Its only downsides are the tingling, itching in topical applications as well as the odor for all applications.  The severity of smell is commiserate with the amount used.

Go here for more:

[DMSO’s] virtues were extolled in another Congressional Hearing, this one taking place on March 24, 1980, before Claude Pepper’s Select House Committee on Aging. The drug was DMSO, and the opponent, as in Senator Johnson’s Hearing, was once again the FDA.

As with Ivermectin, the FDA [Bureau of Drugs] Director, Dr. J. Richard Crout, explained—tongue in cheek—that the agency would be the first to advocate DMSO’s use if it had only evidence that it worked.

“The FDA is willing, indeed anxious, to approve DMSO for such uses whenever controlled trials meeting the statutory standard are available [Page 61].

In place of Dr. Pierre Kory sat Dr. Stanley Jacob, a professor of surgery at the University of Oregon Medical School. Dr. Jacob was the dynamic Harvard-trained physician who headed the University of Oregon Transplant Program and had discovered many of the benefits of DMSO after first using it as a cryoprotectant.

Dr. Jacob testified before the committee in 1980, just as Dr. Kory would do some 40 years later, in 2020, and told an unbelievable story to a group of Washington D.C. insiders about the miraculous benefits of an almost unknown drug.

Like Dr. Kory, he has been proven correct.

Dr. Kory authored a book about his experience entitled The War Against Ivermectin: The Medicine that Saved Millions and Could Have Ended the Pandemic.

Dr. Jacob authored the book Dimethyl Sulfoxide (DMSO) in Trauma and Disease.

DMSO met the same fate in 1980 as Ivermectin did following Dr. Kory’s Congressional hearing in 2020: The FDA buried it.

The FDA shut down research on DMSO in 1965 after an estimated 100,000 patients began enjoying its benefits.

Many states have laws that steer licensed physicians away from prescribing DMSO for anything other than interstitial cystitis.

Sound familiar?

Category:

Activism, Pain Management, research, Treatment